Interferon-γ induces neuroendocrine-like differentiation of human prostate basal-epithelial cells

Prostate

Volumn 64, Issue 4, 2005, Pages 419-429

  Untergasser, Gerold ^a   Plas, Eugen ^b   Pfister, Gerald ^a   Heinrich, Elmar ^a   Berger, Peter ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b GENERAL HOSPITAL LINZ   (Austria)

Author keywords

Aging; Differentiation; Interferon; Neuroendocrine cells; Prostate basal cells

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CHROMOGRANIN A; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYTOKERATIN; CYTOKERATIN 18; CYTOKERATIN 8; GAMMA INTERFERON; NEURON SPECIFIC ENOLASE;

ADULT; AGED; AGING; APOPTOSIS; ARTICLE; BASAL CELL; CELL CYCLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; STEM CELL; TUMOR CELL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE, TUMOR; EPITHELIAL CELLS; GROWTH INHIBITORS; HUMANS; INTERFERON TYPE II; KERATINS; MALE; MOLECULAR WEIGHT; NEUROSECRETORY SYSTEMS; PHENOTYPE; PROSTATE; PROSTATIC NEOPLASMS;

EID: 23944481679     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20261     Document Type: Article

References (45)

1. di Sant'Agnese PA. Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: A review of morphologic aspects. Urology 1998;51(5A Suppl):121-124.
2. Aumuller G, Leonhardt M, Janssen M, Konrad L, Bjartell A, Abrahamsson PA. Neurogenic origin of human prostate endocrine cells. Urology 1999;53(5):1041-1048.
3. Aumuller G, Leonhardt M, Renneberg H, von Rahden B, Bjartell A, Abrahamsson PA. Semiquantitative morphology of human prostatic development and regional distribution of prostatic neuroendocrine cells. Prostate 2001;46(2):108-115.
4. Sommerfeld HJ, Partin AW, Pannek J. Incidence of neuroendocrine cells in the seminal vesicles and the prostate-An immunohistochemical study. Int Urol Nephrol 2002;34(3):357-360.
5. van Leenders GJ, Schalken JA. Epithelial cell differentiation in the human prostate epithelium: Implications for the pathogenesis and therapy of prostate cancer. Crit Rev Oncol Hematol 2003;46(Suppl):S3-S10.
6. Xue Y, van der Laak J, Smedts F, Schools C, Verhofstad A, de la Rosette J, Schalken J. Neuroendocrine cells during human prostate development: Does neuroendocrine cell density remain constant during fetal as well as postnatal life? Prostate 2000; 42(2):116-123.
7. Stridsberg M, Fabiani R, Lukinius A, Ronquist G. Prostasomes are neuroendocrine-like vesicles in human semen. Prostate 1996;29(5):287-295.
8. Schalken JA, van Leenders G. Cellular and molecular biology of the prostate: Stem cell biology. Urology 2003;62(5 Suppl 1):11-20.
9. Rumpold H, Heinrich E, Untergasser G, Hermann M, Pfister G, Plas E, Berger P. Neuroendocrine differentiation of human prostatic primary epithelial cells in vitro. Prostate 2002;53(2): 101-108.
10. Wright ME, Tsai MJ, Aebersold R. Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells. Mol Endocrinol 2003;17(9):1726-1737.
11. Zelivianski S, Verni M, Moore C, Kondrikov D, Taylor R, Lin MF. Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype. Biochim Biophys Acta 2001;1539(1-2):28-43.
12. Abrahamsson PA. Neuroendocrine cells in tumour growth of the prostate. Endocr Relat Cancer 1999;6(4):503-519.
13. di Sant'Agnese PA, Cockett AT. Neuroendocrine differentiation in prostatic malignancy. Cancer 1996;78(2):357-361.
14. Royuela M, de Miguel MP, Ruiz A, Fraile B, Arenas MI, Romo E, Paniagua R. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: Parallelism with c-myc and p53 expression. Eur Cytokine Netw 2000;11(1):119-127.
15. Steiner GE, Stix U, Handisurya A, Willheim M, Haitel A, Reithmayr F, Paikl D, Ecker RC, Hrachowitz K, Kramer G, Lee C, Marberger M. Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab Invest 2003;83(8):1131-1146.
16. Bostwick DG, de la Roza G, Dundore P, Corica FA, Iczkowski KA. Intraepithelial and stromal lymphocytes in the normal human prostate. Prostate 2003;55(3):187-193.
17. Platz EA, De Marzo AM. Epidemiology of inflammation and prostate cancer. J Urol 2004;171(2 Pt 2):S36-S40.
18. Untergasser G, Koch HB, Menssen A, Hermeking H. Characterization of epithelial senescence by serial analysis of gene expression: Identification of genes potentially involved in prostate cancer. Cancer Res 2002;62(21):6255-6262.
19. Untergasser G, Gander R, Rumpold H, Heinrich E, Plas E, Berger P. TGF-beta cytokines increase senescence-associated beta galactosidase activity in human prostate basal cells by supporting differentiation proceses, but not cellular senescence. Exp Gerontol 2003;38:1179-1188.
20. Bang YJ, Pirnia F, Fang WG, Kang WK, Sartor O, Whitesell L, Ha MJ, Tsokos M, Sheahan MD, Nguyen P, Nikilinski WT, Myers CE, Trepel JB. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci USA 1994;91(12):5330- 5334.
21. Abrahamsson PA. Neuroendocrine differentiation and hormone-refractory prostate cancer. Prostate Suppl 1996;6:3-8.
22. Cockett AT, di Sant' Agnese PA, Gopinath P, Schoen SR, Abrahamsson PA. Relationship of neuroendocrine cells of prostate and serotonin to benign prostatic hyperplasia. Urology 1993;42(5):512-519.
23. Mouland AJ, Bevan S, White JH, Hendy GN. Human chromo granin a gene. Molecular cloning, structural analysis, and neuroendocrine cell-specific expression. J Biol Chem 1994; 269(9):6918-6926.
24. Xue Y, Verhofstad A, Lange W, Smedts F, Debruyne F, de la Rosette J, Schalken J. Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: Cell kinetic features of neuroendocrine cells in the human prostate. Am J Pathol 1997;151(6):1759-1765.
25. Liu WK, Ho JC, Qin G, Che CT. Jolkinolide B induces neuroendocrine differentiation of human prostate LNCaP cancer cell line. Biochem Pharmacol 2002;63(5):951-957.
26. Huss WJ, Gregory CW, Smith GJ. Neuroendocrine cell differentiation in the CWR22 human prostate cancer xenograft: Association with tumor cell proliferation prior to recurrence. Prostate 2004;60(2):91-97.
27. Zhang XQ, Kondrikov D, Yuan TC, Lin FF, Hansen J, Lin MF. Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells. Oncogene 2003;22(43):6704-6716.
28. Xie S, Lin HK, Ni J, Yang L, Wang L, di Sant'Agnese PA, Chang C. Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells. Prostate 2004;60(1):61-67.
29. Goodin JL, Rutherford CL. Identification of differentially expressed genes during cyclic adenosine monophosphate-induced neuroendocrine differentiation in the human prostatic adenocarcinoma cell line LNCaP. Mol Carcinog 2002;33(2):88-98.
30. Deeble PD, Murphy DJ, Parsons SJ, Cox ME. Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells. Mol Cell Biol 2001;21(24):8471-8482.
31. Cox ME, Deeble PD, Bissonette EA, Parsons SJ. Activated 3′,5′-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line. J Biol Chem 2000;275(18):13812-13818.
32. Wang Q, Horiatis D, Pinski J. Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation. Int J Cancer 2004;111(4):508-513.
33. Qiu Y, Robinson D, Pretlow TG, Kung HJ. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc Natl Acad Sci USA 1998;95(7):3644-3649.
34. Mori S, Murakami-Mori K, Bonavida B. Interleukin-6 induces G1 arrest through induction of p27(Kip1): A cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells. Biochem Biophys Res Commun 1999;257(2):609-614.
35. Chiao JW, Hsieh TC, Xu W, Sklarew RJ, Kancherla R. Development of human prostate cancer cells to neuroendocrine-like cells by interleukin-1. Int J Oncol 1999;15(5):1033-1037.
36. Diaz M, Abdul M, Hoosein N. Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2. Prostate Suppl 1998;8:32-36.
37. Kominsky SL, Hobeika AC, Lake FA, Torres BA, Johnson HM. Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells. Cancer Res 2000;60(14):3904-3908.
38. Pagan R, Sanchez A, Martin I, Llobera M, Fabregat I, Vilaro S. Effects of growth and differentiation factors on the epithelial-mesenchymal transition in cultured neonatal rat hepatocytes. J Hepatol 1999;31(5):895-904.
39. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001;159(4):1465-1475.
40. Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA, Albertsen P, Kreutzer DL. Interleukin-10 levels in seminal plasma: Implications for chronic prostatitis-chronic pelvic pain syndrome. J Urol 2002;167(2 Pt 1):753-756.
41. Kramer G, Steiner GE, Handisurya A, Stix U, Haitel A, Knerer B, Gessl A, Lee C, Marberger M. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate 2002;52(1):43-58.
42. Lee LF, Guan J, Qiu K, Kung HJ. Neuropeptide-induced androgen independence in prostate cancer cells: Roles of nonreceptor tyrosine kinases Etk/Bmx, src, and focal adhesion kinase. Mol Cell Biol 2001;21(24):8385-8387.
43. Vilches J, Salid JM, Ferandez-Segur AE, Roomans GM. Neuropeptides, apoptosis and ion changes in prostate cancer. Methods of study and recent developments. Histo Histopathol 2004;19(3): 951-961.
44. Xiao D, Qu X, Weber HC. GRP-receptor mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells. Regul Prpt 2002;109(1-3):141-148.
45. Levine L, Lucci JA, Paz Drak B, Cheng JZ, Guo YS, Townsend CM, Hellmich MR. Borbesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Cancer Res 2003;63(13):3495- 3502.